Initial Experience with the Contour Device in the Treatment of Ruptured Intracranial Wide-necked Bifurcation Aneurysms: A Single-operator, Multicenter Study

医学 改良兰金量表 动脉瘤 前交通动脉 放射科 大脑中动脉 分流器 大脑前动脉 外科 基底动脉 介绍(产科) 血管内治疗 心脏病学 缺血 缺血性中风
作者
Nitin Dange,Joanna M. Roy
出处
期刊:Neurology India [Medknow Publications]
卷期号:70 (5): 2059-2059 被引量:1
标识
DOI:10.4103/0028-3886.359281
摘要

Background: Intrasaccular flow diverters are a new modality in the treatment of intracranial aneurysms. The Contour device has been designed to offer a variety of advantages over existing endovascular treatment options for wide-necked bifurcation aneurysms. There is no available literature describing its use in treating ruptured aneurysms.Objective: To assess the safety, outcome, and efficacy of the Contour device as a primary modality in treating ruptured intracranial aneurysms.Materials And Methods: A retrospective analysis of 14 aneurysms in 13 patients treated with the Contour device was studied. Data pertaining to demographics, clinical presentation on arrival, aneurysmal characteristics, and follow-up outcome was collected. The Hunt–Hess scale and modified Rankin scale were used to grade severity of clinical presentation.Results: Of the 14 aneurysms treated, one was unruptured and 13 were ruptured. Six middle cerebral artery aneurysms, six anterior communicating artery, one basilar top and one distal anterior cerebral artery aneurysm were treated. Coiling was required in two patients due to the large size of their aneurysms. No thromboembolic complications or intraoperative rupture was reported following device placement. Two patients required antiplatelet therapy for 6 weeks. A median follow-up at 3 months revealed stable placement of the device within the aneurysm and no sign of residual aneurysm or rebleed.Conclusion: Initial experience with Contour in treating ruptured aneurysms has shown favorable immediate and short-term follow-up outcome. However, long-term follow-up studies are required to assess its safety and long-term efficacy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
打打应助英俊的含蕾采纳,获得10
1秒前
ZeSheng完成签到,获得积分10
2秒前
2秒前
4秒前
月出西山上完成签到 ,获得积分10
4秒前
李静完成签到,获得积分10
4秒前
黄74185296完成签到 ,获得积分10
5秒前
胡建完成签到,获得积分10
7秒前
8秒前
8秒前
赖不弱发布了新的文献求助10
9秒前
9秒前
小杰杰发布了新的文献求助10
11秒前
14秒前
2021的萌爷爷应助Friday采纳,获得50
14秒前
jwb711发布了新的文献求助30
15秒前
个性松完成签到 ,获得积分10
17秒前
彭于晏应助从容代丝采纳,获得10
17秒前
通达完成签到,获得积分10
18秒前
脑洞疼应助烂漫念文采纳,获得10
19秒前
安静鸽哥发布了新的文献求助10
19秒前
伶俐绿柏完成签到,获得积分10
19秒前
小杰杰完成签到,获得积分10
20秒前
汉堡包应助小猪采纳,获得10
22秒前
22秒前
sxy完成签到,获得积分10
23秒前
李健应助jwb711采纳,获得10
24秒前
Sky完成签到,获得积分10
24秒前
zhu完成签到,获得积分10
24秒前
orixero应助奋斗的杰采纳,获得10
25秒前
xx发布了新的文献求助10
26秒前
文献啊文献完成签到,获得积分20
28秒前
星辰大海应助ddded采纳,获得10
29秒前
30秒前
孙小雨完成签到,获得积分10
31秒前
32秒前
nice1334完成签到,获得积分10
32秒前
33秒前
ertytryt完成签到,获得积分10
33秒前
34秒前
高分求助中
Pharmacogenomics: Applications to Patient Care, Third Edition 1000
Studien zur Ideengeschichte der Gesetzgebung 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Genera Insectorum: Mantodea, Fam. Mantidæ, Subfam. Hymenopodinæ (Classic Reprint) 800
Ethnicities: Media, Health, and Coping 700
Development of a new synthetic process for the synthesis of (S)-methadone and (S)- and (R)-isomethadone as NMDA receptor antagonists for the treatment of depression 500
A Dissection Guide & Atlas to the Rabbit 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3089165
求助须知:如何正确求助?哪些是违规求助? 2741290
关于积分的说明 7564290
捐赠科研通 2391558
什么是DOI,文献DOI怎么找? 1268291
科研通“疑难数据库(出版商)”最低求助积分说明 614044
版权声明 598684